insights_auto
Why is MBIO down 2.44%?
Dive Deeperchevron_right
MBIO:NASDAQ
Mustang Bio Inc
$0.40
arrow_downward
-2.44%(-0.010) 1D
$0.40
arrow_upward
+1.15% (+0.0046)bedtimeAfter hours
Closed: Oct 9, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MBIO...
Open
$0.43
High
$0.43
Low
$0.38
Mkt. cap
3.01M
Avg. vol.
29.09K
Volume
99.18K
52-wk high
$1.80
52-wk low
$0.38
EPS
-$0.46
Beta
2.09
Shares outstanding
6.73M
No. of employees
4
Open
$0.43
High
$0.43
Low
$0.38
Mkt. cap
3.01M
Avg. vol.
29.09K
Volume
99.18K
52-wk high
$1.80
52-wk low
$0.38
EPS
-$0.46
Beta
2.09
Shares outstanding
6.73M
No. of employees
4
News stories
From web sources and news partners
BeInCrypto
·
36 minutes ago
A Few Stocks Carry the S&P 500: 41% of Stocks Trade 30% Below Highs
FXLeaders
·
4 hours ago
Dow Jones and Nasdaq Futures Start Higher Ahead of US Inflation Data
CryptoRank
·
12 hours ago
Pokémon Cards Just Crushed Bitcoin, Gold and the S&P 500 With 150% Returns
Traders Union
·
6 hours ago
Yuriy Matso: S&P500 negative beta to SPY at record 18.9 percent
Profile
Mustang Bio is an American clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency. Wikipedia
About Mustang Bio Inc
CEOManuel Litchman
Employees4
Founded2015
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Websitemustangbio.com